Delivery Order SPE2DB20D3101-SPE2DB22FH4U6
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,728.95 firm fixed-price delivery order is for Nitro-Dur 0.3 mg/hr patches. This contract is not designated with a set-aside requirement. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Nitro-Dur 0.3 mg/hr Patch medical supplies. The contract, valued at $12,618.12, is a firm fixed-price delivery order with a period of performance through June 27, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is a delivery order valued at $10,732.20 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Nitro-Dur 0.3 mg/hr patch. The contract has an ultimate completion date of October 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the agency to efficiently...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,589.73 firm fixed-price delivery order is for the supply of Nitro-Dur 0.3 mg/hr patch, a medical product used for cardiovascular health. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to...
- This federal contract award, valued at $27,117.43, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of NITRO-DUR 0.3 MG/HR PATCH 30S, a pharmaceutical product, and has an ultimate completion date of August 2, 2022. The contract was awarded as a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $43,637.65 firm fixed price delivery order is for the supply of NITRO-DUR 0.3 MG/HR patch medical products. The award has an ultimate completion date of July 9, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,758.60 firm fixed-price delivery order is for the supply of NITRO-DUR 0.8 MG/HR Patch 30S, a cardiovascular medication, with an ultimate completion date of November 21, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award, valued at $18,856.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of NITRO-DUR 0.3 MG/HR transdermal patches, with a completion date of September 28, 2022. This is a firm-fixed-price delivery order, and the contract was not set aside for any particular business type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has established itself as a...
- This federal contract award, valued at $3,179.46, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of NITRO-DUR 0.3 MG/HR PATCH 30S, a medical product, with a completion date of October 27, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,206.27 Firm Fixed Price Delivery Order is for the supply of NITRO-DUR 0.3 MG/HR PATCH 30S, a medical product used for cardiac care. The contract has an ultimate completion date of November 15, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB22FH4U6Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,032.86 firm fixed-price delivery order is for the supply of Nitro-Dur 0.3 mg/hr Patch under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 and running through November 2026. The contract supports military healthcare programs by providing a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. No set-aside designation was used for this award. Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 1/13/22 |